Chemio- E Immunoterapia Topica Nelle Forme Superficiali Del Carcinoma Transizionale Della Vescica

Ackermann R. : Treatment of superficial bladder tumors with recombinant α-2-interferon. XX Kongr. Internat. Gesellschaft für Urologie, p. 329. Wien, 23-28 giugno 1985.

Brosman S. : Experience with bacillus Calmette-Guérin in patients with a superficial bladder carcinoma. J. Urol., 128; 27 (1982).

Brosman S. : The use of bacillus Calmette-Guérin in the therapy of bladder carcinoma in situ J. Urol., 134; 36 (1985).

Catalona W. J. , Smolev J. K. , Harty S. I. : Prognostic value of host immunocompetence in urologic cancer patients. J. Urol., 114; 922 (1975).

Catalona W. J. : Commentary on the immunobiology of bladder cancer J. Urol., 115; 2 (1977).

Defidio L. , Sabatini G. , Brisciani A. , Ammaturo F. , De Paula F. : Possono trattamenti endocavitari multipli essere causa di vescica retratta? Nuova Stampa med. ital. 4; 37 (1984).

De Kernion J. B. , Huang Ming Yang , Lindner A. , Smith K. B. , Kaufman J. J. : The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guérin. J. Urol., 133; 599 (1985).

Droller M. J. : Immunotherapy in genitourinary neoplasia. Urol. Clin. N. Amer., 144; 643 (1984).

Edshyr F. , Andersson L. , Esposti P. L. : Intravesical chemotherapy of carcinoma in situ in bladder cancer. Urology, 23; 37 (1984).

Garnick M. B. , Schade D. , Israel M. , Maxwell B. , Richie J. : Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma. J. Urol., 131; 43 (1984).

Herr H. W. : Carcinoma in situ of the bladder. Seminars in urology, 1; 15 (1983).

Herr H. W. , Pinsky C. M. , Whitmore W. F. , Oettgen H. F. , Melamed M. R. : Effect of intravesical BCG on carcinoma in situ of the bladder-cancer (in press).

Huland H. , Otto U. , Droese M. , Klöppel G. : Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival. J. Urol., 132; 27 (1984).

Jakse G. , Hofstadter F. , Marberger H. : Topical doxorubicin hydrochloride therapy for carcinoma in situ of the bladder: a follow-up. J. Urol., 131 41 (1984).

Kelley D. R. , Ratliff T. L. , Catalona W. J. , Shapiro A. , Lage J. M. , Bauer W. C. , Haaf E. O. , Dresner S. M. : Intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer: effect of bacillus Calmette-Guérin viability on treatment results. J. Urol., 134; 48 (1985).

Lamm D. L. , Thor D. E. , Harris S. C. , Reyna J. A. , Stogdill V. D. , Rawin H. M. : BCG immunotherapy of superficial bladder cancer. J. Urol., 124; 38 (1980).

Lamm D. L. , Thor D. E. , Winters W. D. , Stogdill V. D. , Radwin H. M. : BCG immunotherapy of bladder cancer: inhibition of tumor recurrence and associated immune responses. Cancer, 48; 82 (1981).

Lamm D. L. , Thor D. E. , Stogdill U. D. , Radwin H. M. : Bladder cancer immunotherapy. J. Urol., 128; 931 (1982).

Lamm D. L. , Reichert D. F. , Harris S. C. , Ruben M. L. : Immunotherapy of murine transitional cell carcinoma. J. Urol., 128; 1104 (1982).

Lamm D. L. : Bacillus Calmette-Guérin immunotherapy for bladder cancer. J. Urol., 124; 40 (1985).

Martínez-Piñeiro S. A. : Management of superficial bladder carcinoma with BCG long-term follow-up. Bladder cancer, Part B, 335–345. Alan R. Liss, Inc., New York 1984.

Morales A. , Eidinger D. , Bruce A. W. : Intracavitary BCG in the treatment of superficial bladder tumors. J. Urol., 116; 180 (1975).

Morales A. : Treatment of carcinoma in situ of the bladder with BCG: a phase II Trial. Cancer Immunol. Immunother., 1; 69 (1980).

Morales A. , Ottenhof P. , Emerson L. : Treatment of residual non-infiltrating bladder cancer with BCG. J. Urol., 125; 649 (1981).

Morales A. : Long-term results and complications of intracavitary BCG therapy for bladder cancer. J. Urol., 132; 457 (1984).

Nelson R. Jr. , Caserta Lemos G. : BCG immunotherapy of infiltrating bladder cancer. J. Urol., 132; 675 (1984).

Pang A. S. , Morales A. : BCG induced murine peritoneal exudate cells: citotoxic activity against a syngenic bladder tumor cell line. J. Urol., 127; 1225 (1982).

Pang A. S. , Morales A. : Immunoprophylaxis of a murine bladder cancer with high dose BCG immunizations. J. Urol., 127; 1006 (1982).

Pansadoro V. , Defidio L. , De Paula F. , Sabatini G. , Brisciani A. : Efficacia della mitomicina in relazione al grado istologico nel trattamento dei tumori vescicali. Urologia, 50; 1028 (1983).

Pavone-Macaluso M. , Ingargiola G. B. , Trini M. , Lamartina M. : Intravesical instillation of adriamycin in treatment of bladder cancer: a review. Urology, 23; 40 (1984).

Pizza G. , Severini G. , Menniti D. , De Vinci C. , Corrado F. : Tumor regression after intralesional injection of interleukin 2(IL-2) in bladder cancer. Preliminary report. Intern. J. Cancer., 34; 359–367 (1984).

Pontes J. E. , Dhabuwala C. B. , Pierce J. M. : Intravesical adriamycin therapy for bladder cancer: long term results. Urology. 23; 35 (1984).

Reicher D. F. , Lamm D. L. : Long-term protection in bladder cancer following intralesional immunotherapy. J. Urol., 132; 570 (1984).

Shaprio A. , Ratliff T. L. , Oakley D. M. , Catalona W. J. : Comparison of the efficacy of intravesical BCG with thiotepa, mitomycin C. Poly I: C/Poly-L-Lysine and Cis-Platinum in murine bladder cancer. J. Urol., 131; 139 (1984).

Soloway M. : Rationale for intensive intravesical chemoterapy for superficial blalder cancer. J. Urol., 123; 461 (1980).

Soloway M. S. : Intravesical and systemic chemotherapy in the management of suoerficial bladder cancer. Urol. Clin. N. Amer., 11; 637 (1984).

Suzuki Tadashi : BCG and interferon immunotherapy of bladder tumor. XX Kongr. Intern. Gesellschaft für Urologie, p. 329. Wien, 28-28 giugno 1985.

Yonese Y. : Interferon therapy in bladder cancer. XX Kongr. Intern. Gesellschaft für Urologie, p. 330. Wien. 23-28 giugno 1985.

Waisman Z. , McGill W. , Englander L. , Huben R. P. , Pontes J. E. : Severely contracted bladder following intravesical mitomicin C therapy. J. Urol., 130; 340 (1983).

Williams R. D. : Intravesical interferon treatment of superficial bladder cancer. XX Kongr. Intern. Gesellschaft für Urologie, p. 331. Wien, 23-28 giugno 1985.